By a GenomeWeb staff reporter
 
NEW YORK (GenomeWeb News) – French cell-based assays developer Cytoo said this week that it has raised $10 million in a Series C financing round.

The round included new investors Sham, which is a French mutual insurance company, and venture capital firm Entrepreneurs Fund. Previous investors including Auriga Partners and Cytoo Co-founder and Supervisory Board President Jacques Lewiner also participated in the financing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.